SMOLDERING MULTIPLE MYELOMA
Clinical trials for SMOLDERING MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new SMOLDERING MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for SMOLDERING MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a bone drug stop smoldering myeloma from becoming active cancer?
Disease control CompletedThis study tested the safety of denosumab, a drug usually used for bone health, in 20 people with smoldering multiple myeloma (a pre-cancer condition). The goal was to see if denosumab could lower their risk of developing active multiple myeloma. Researchers tracked changes in ri…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New antibody shows promise in slowing Early-Stage bone marrow cancer
Disease control CompletedThis study tested an experimental antibody drug called IPH2101 in 30 people with smoldering multiple myeloma, an early form of bone marrow cancer. The goal was to see if the drug could shrink or slow the cancer while checking for side effects. Participants received one of two dos…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Innate Pharma • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New scans may catch bone marrow cancer earlier
Knowledge-focused CompletedThis study looked at whether newer imaging scans can better detect when early blood disorders (MGUS and smoldering myeloma) turn into active multiple myeloma. Thirty-one adults with these conditions received three types of scans to compare their results. The goal was to improve m…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC
-
Scientists dig into medical records to predict who gets Full-Blown myeloma
Knowledge-focused CompletedThis study looked back at the medical records of 431 people with smoldering multiple myeloma (SMM), a pre-cancer condition. The goal was to see how the disease behaves in real life, especially for those at high risk of progressing to active multiple myeloma. Researchers tracked t…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Sponsor: Janssen-Cilag Ltd. • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC